Search

Your search keyword '"Vill, Katharina"' showing total 288 results

Search Constraints

Start Over You searched for: Author "Vill, Katharina" Remove constraint Author: "Vill, Katharina"
288 results on '"Vill, Katharina"'

Search Results

1. Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings

2. ARF1-related disorder: phenotypic and molecular spectrum.

4. SNUPN deficiency causes a recessive muscular dystrophy due to RNA mis-splicing and ECM dysregulation

5. 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2

7. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

11. Cortical impairment and reduced muscle mass in children and young adults with nephropathic cystinosis.

12. Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features.

13. Long-Term Socioeconomic and Neurologic Outcome for Individuals with Childhood-Onset Multiple Sclerosis.

14. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.

15. Monogenic variants in dystonia: an exome-wide sequencing study

16. Instrumented Balance Error Scoring System in Children and Adolescents—A Cross Sectional Study

18. 1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy

23. Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies

24. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial

28. Next-generation phenotyping integrated in a national framework for patients with ultra-rare disorders improves genetic diagnostics and yields new molecular findings

29. Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia

31. Newbornscreening SMA – From Pilot Project to Nationwide Screening in Germany

36. International Paediatric Mitochondrial Disease Scale

40. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden?

41. [Untitled]

42. Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy

44. Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study

45. Neugeborenenscreeningprogramm für die spinale Muskelatrophie

46. Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset

49. Challenges in Establishing the Diagnosis of PRRT2‐Related Dystonia: Recurrent Pathogenic Variants in a Homopolymeric Stretch.

50. Erratum: De novo stop-loss variants in CLDN11 cause hypomyelinating leukodystrophy (Brain (2020) 144 (411-419) DOI: 10.1093/brain/awaa410)

Catalog

Books, media, physical & digital resources